# Akebia Therapeutics Inc. (AKBA) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $23M |
| 2024 | -$50M |
| 2023 | -$46M |
| 2022 | -$81M |
| 2021 | -$265M |
| 2020 | -$378M |
| 2019 | -$286M |
| 2018 | -$178M |
| 2017 | -$77M |
| 2016 | -$136M |
| 2015 | -$62M |
| 2014 | -$38M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$5M |
| 2025-09-30 | $4M |
| 2025-06-30 | $14M |
| 2025-03-31 | $14M |
| 2024-09-30 | -$13M |
| 2024-06-30 | -$9M |
| 2024-03-31 | -$15M |
| 2023-09-30 | -$13M |
| 2023-06-30 | -$9M |
| 2023-03-31 | -$26M |
| 2022-09-30 | -$50M |
| 2022-06-30 | $34M |
| 2022-03-31 | -$60M |
| 2021-09-30 | -$55M |
| 2021-06-30 | -$79M |
| 2021-03-31 | -$65M |
| 2020-09-30 | -$58M |
| 2020-06-30 | -$174M |
| 2020-03-31 | -$59M |
| 2019-09-30 | -$56M |
| 2019-06-30 | -$60M |
| 2019-03-31 | -$76M |
| 2018-09-30 | -$28M |
| 2018-06-30 | -$36M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AKBA/operating-income)